Skip to main content

Table 1 Patient characteristics and comparison between patients with and without anemia

From: Renal resistive index as an indicator of the presence and severity of anemia and its future development in patients with hypertension

 

All

Anemia

No anemia

p value

Demographic data

    

Number

175

64

111

 

Age, years

67 ± 11

71 ± 10

65 ± 11

<0.01

Males, number (%)

134 (76.6)

50 (78.1)

84 (75.7)

0.71

Body mass index, kg/m2

24.2 ± 3.9

23.7 ± 4.5

24.6 ± 3.5

0.02

Systolic blood pressure, mmHg

135 ± 18

137 ± 20

135 ± 17

0.59

Diastolic blood pressure, mmHg

75 ± 13

72 ± 14

76 ± 13

0.01

Pulse pressure, mmHg

61 ± 15

64 ± 17

59 ± 14

0.02

Heart rate, bpm

67 ± 11

67 ± 10

67 ± 12

0.98

Resistive index

0.70 ± 0.09

0.74 ± 0.09

0.67 ± 0.08

<0.01

Left ventricular ejection fraction

0.63 ± 0.12

0.63 ± 0.14

0.64 ± 0.11

0.92

Laboratory data

    

Hemoglobin, g/dl

13.1 ± 1.7

11.4 ± 1.0

14.1 ± 1.2

<0.01

Estimated GFR, ml/min./1.73 m2

57.7 ± 23.1

48.3 ± 24.8

63.1 ± 20.3

<0.01

Qualitative urine protein, number (%)

51 (29.3)

31 (49.2)

20 (18.0)

<0.01

Hemoglobin A1c, %

6.4 ± 1.7

6.6 ± 2.1

6.4 ± 1.4

0.98

Comorbidities, number (%)

    

Diabetes mellitus

91 (52.0)

35 (54.7)

56 (50.5)

0.60

Dyslipidemia

122 (69.7)

46 (71.9)

76 (68.5)

0.64

Coronary artery disease

104 (59.4)

41 (64.1)

63 (56.8)

0.34

Peripheral artery disease

34 (19.4)

16 (25.0)

18 (16.2)

0.16

History of congestive heart failure

12 (6.8)

6 (9.4)

6 (5.4)

0.35

History of cerebral infarction

26 (14.9)

12 (18.8)

14 (12.6)

0.30

Current smoking

53 (30.6)

19 (30.2)

34 (30.9)

0.92

COPD

8 (4.6)

4 (3.6)

4 (6.3)

0.41

Medications, number (%)

    

RAAS inhibitors

125 (71.4)

52 (81.3)

73 (65.8)

0.02

Calcium channel blockers

114 (65.1)

47 (73.4)

67 (60.4)

0.07

Beta blockers

57 (32.6)

17 (26.6)

40 (36.0)

0.20

Statins

92 (52.6)

37 (57.8)

55 (49.5)

0.29

  1. Values are expressed as mean ± SD or numbers and percentages. Student’s t test was used to assess differences between the two groups except for sex, qualitative urine protein, comorbidities and medications, for which chi-square test was used.
  2. GFR, glomerular filtration rate; COPD, chronic obstructive pulmonary disease; RAAS, renin-angiotensin-aldosterone system.